p38 MAPK contributes to CD54 expression and the enhancement of phagocytic activity during macrophage development

被引:14
作者
Cui, Jian [1 ]
Zhu, Ning [2 ]
Wang, Qingyang [1 ]
Yu, Ming [1 ]
Feng, Jiannan [1 ]
Li, Yan [1 ]
Zhang, Jiyan [1 ]
Shen, Beifen [1 ]
机构
[1] Inst Basic Med Sci, Dept Mol Immunol, Beijing 100850, Peoples R China
[2] Henan Univ, Lab Cellular & Mol Immunol, Kaifeng, Peoples R China
基金
中国国家自然科学基金;
关键词
p38; Macrophage; Development; CD54; Phagocytosis; NF-KAPPA-B; CELL PROLIFERATION; KINASE; ACTIVATION; PROTEIN; PATHWAY; DIFFERENTIATION; INHIBITION; JNK;
D O I
10.1016/j.cellimm.2008.12.003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
p38 is a subfamily of the mitogen-activated protein kinase (MAPK) superfamily with four isoforms. It has been well established that p38 plays a central role in the production of inflammatory molecules and is therefore required for the activation of macrophages in response to inflammatory stimuli. However, little is known about the roles of p38 in macrophage development. The difficulty to get mice deficient in multiple p38 isoforms complicates the study of p38 in macrophage development. With the model of bone marrow-derived murine macrophages and highly selective p38 alpha/beta inhibitors SB203580 and SB239063, here we report that macrophage colony-stimulating factor (M-CSF) induces p38 activation during macrophage development. Inhibition of p38 activity showed minor effects on macrophage proliferation or survival, and did not block CD14, F4/80 expression. However, p38 inhibitors resulted in a significant reduction in CD54 expression and impaired phagocytic activity. Taken together, our data suggest that p38 contributes to macrophage development. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 29 条
[1]  
[Anonymous], NAT MED
[2]   The many paths to p38 mitogen-activated protein kinase activation in the immune system [J].
Ashwell, Jonathan D. .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (07) :532-540
[3]   Generation and characterization of p38β (MAPK11) gene-targeted mice [J].
Beardmore, VA ;
Hinton, HJ ;
Eftychi, C ;
Apostolaki, M ;
Armaka, M ;
Darragh, J ;
McIlrath, J ;
Carr, JM ;
Armit, LJ ;
Clacher, C ;
Malone, L ;
Kollias, G ;
Arthur, JSC .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (23) :10454-10464
[4]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[5]   Macrophage glucocorticoid receptors regulate toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase [J].
Bhattacharyya, Sandip ;
Brown, Diane E. ;
Brewer, Judson A. ;
Vogt, Sherri K. ;
Muglia, Louis J. .
BLOOD, 2007, 109 (10) :4313-4319
[6]   SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233
[7]   SYNERGISM OF INTERLEUKIN-6 AND 1-ALPHA,25-DIHYDROXYVITAMIN D3 IN INDUCTION OF MYELOID DIFFERENTIATION OF HUMAN LEUKEMIC-CELL LINES [J].
DUITS, AJ ;
DIMJATI, W ;
VANDEWINKEL, JGJ ;
CAPEL, PJA .
JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 51 (03) :237-243
[8]   The JNK are important for development and survival of macrophages [J].
Himes, SR ;
Sester, DP ;
Ravasi, T ;
Cronau, SL ;
Sasmono, T ;
Hume, DA .
JOURNAL OF IMMUNOLOGY, 2006, 176 (04) :2219-2228
[9]  
Huang ZW, 1997, BIOPOLYMERS, V43, P367, DOI 10.1002/(SICI)1097-0282(1997)43:5<367::AID-BIP3>3.0.CO
[10]  
2-T